Molecule Holdings Inc.
MLCL
CNSX
| 07/31/2023 | 04/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 334.58% | -57.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 334.58% | -57.58% | |||
| Cost of Revenue | 186.58% | -68.89% | |||
| Gross Profit | 10,305.56% | 101.80% | |||
| SG&A Expenses | 78.09% | -52.05% | |||
| Depreciation & Amortization | 347.95% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 121.68% | -59.31% | |||
| Operating Income | -4.73% | 60.22% | |||
| Income Before Tax | -23.54% | 5.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.54% | 5.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.54% | 5.54% | |||
| EBIT | -4.73% | 60.22% | |||
| EBITDA | -7.22% | 75.12% | |||
| EPS Basic | -22.45% | 5.77% | |||
| Normalized Basic EPS | -52.00% | 21.88% | |||
| EPS Diluted | -53.06% | 5.77% | |||
| Normalized Diluted EPS | -52.00% | 21.88% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||